GSK N 38 "VIRAZH", Samara Oblast

Accounting reports

Previously








Share:
Name
Garazhno-stroitel'nyy kooperativ N 38 "VIRAZH"
INN
6323042471
KPP
632401001
OGRN
1036300994388
OKPO
48097256
Address
445007, Samarskaya Oblast', g. Tol'yatti, b-r 50 Let Oktyabrya, d. D.75 A
Phone
+7 (848) 222-59-59

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
GSK N 38 "VIRAZH" according to EGRUL

OKVED codeTypeName of activity type
52.21.24Core activity Activities of Parking for vehicles
Registration date
23.01.2003
Registering department
MEZHRAYONNAYA IFNS ROSSII N 2 PO SAMARSKOY OBLASTI

GSK N 38 "VIRAZH" (Samara Oblast; INN 6323042471) was registered on 23 Jan 2003. Type of ownership of GSK N 38 "VIRAZH" - Comsumer cooperatives.

Form of ownership of GSK N 38 "VIRAZH" - Private property.

Principal activities of GSK N 38 "VIRAZH": activities of parking for vehicles (52.21.24).

Economic indicators

2022

Net profit (RAS) of GSK N 38 VIRAZH dropped in 2022 2.18 times to 102.00 thousand RUB from 222.00 thousand RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period by 7.82% to 2.22 million RUB from 2.41 million RUB in 2021; cost of goods sold decreased by 3.11% to 2.12 million RUB from 2.18 million RUB; sales profit fell 2.18 times to 102.00 thousand RUB from 222.00 thousand RUB.

2021

Net profit (RAS) of GSK N 38 VIRAZH grew over 2021 10.57 times to 222.00 thousand RUB from 21.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period by 25.72% to 2.41 million RUB from 1.91 million RUB over 2020; cost of goods sold grew by 15.38% to 2.18 million RUB from 1.89 million RUB; sales profit went up 10.57 times to 222.00 thousand RUB from 21.00 thousand RUB.

2020

Net profit (RAS) of GSK N 38 VIRAZH grew over 2020 by 40.00% to 21.00 thousand RUB from 15.00 thousand RUB over 2019, the company informed.

Revenue decreased in the accounting period by 7.50% to 1.91 million RUB from 2.07 million RUB in 2019; cost of goods sold decreased by 7.84% to 1.89 million RUB from 2.05 million RUB; sales profit went up by 40.00% to 21.00 thousand RUB from 15.00 thousand RUB.

2019

Net profit (RAS) of GSK N 38 VIRAZH dropped in 2019 12.40 times to 15.00 thousand RUB from 186.00 thousand RUB over the same period in 2018, the company informed.

Revenue decreased in the accounting period by 12.19% to 2.07 million RUB from 2.36 million RUB in 2018; cost of goods sold decreased by 5.35% to 2.05 million RUB from 2.17 million RUB; sales profit fell 12.40 times to 15.00 thousand RUB from 186.00 thousand RUB.

2018

Net profit (RAS) of GSK N 38 VIRAZH grew over 2018 4.04 times to 186.00 thousand RUB from 46.00 thousand RUB over 2017, the company informed.

Revenue increased in the accounting period by 16.18% to 2.36 million RUB from 2.03 million RUB over 2017; cost of goods sold grew by 9.49% to 2.17 million RUB from 1.98 million RUB; sales profit went up 4.04 times to 186.00 thousand RUB from 46.00 thousand RUB.

2017

Net profit (RAS) of GSK N 38 VIRAZH grew over 2017 3.54 times to 46.00 thousand RUB from 13.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period by 2.95% to 2.03 million RUB from 1.97 million RUB over 2016; cost of goods sold grew by 1.28% to 1.98 million RUB from 1.96 million RUB; sales profit went up 3.54 times to 46.00 thousand RUB from 13.00 thousand RUB.

2016

Net profit (RAS) of GSK N 38 VIRAZH dropped in 2016 14.46 times to 13.00 thousand RUB from 188.00 thousand RUB over the same period in 2015, the company informed.

Revenue increased in the accounting period by 2.71% to 1.97 million RUB from 1.92 million RUB over 2015; cost of goods sold grew by 13.13% to 1.96 million RUB from 1.73 million RUB; sales profit fell 14.46 times to 13.00 thousand RUB from 188.00 thousand RUB.

2014

Net profit (RAS) of GSK 38 VIRAZH made up 0 RUB over 2014 compared to net loss of 353.00 thousand RUB over 2013, the company informed.

Revenue increased in the accounting period by 34.65% to 2.70 million RUB from 2.00 million RUB over 2013; cost of goods sold grew by 14.47% to 2.70 million RUB from 2.36 million RUB; sales profit made up 0 compared to net loss of 353.00 thousand RUB.

2013




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 316 765
Reports
17 430 671
Rrocessed requests
Extract from EGRUL:
Today, 2:27 PM
Accounting reports:
Today, 2:25 PM
The site can contain materials of 16+ category
+7(495) 729−17−96,    info@k-agent.ru
Рейтинг@Mail.ru © "Info-RL", 2006—2024
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru